The project of Russian clinical practice guidelines for diagnosis and treatment of differentiated thyroid cancer is dedicated to the management of patients with differentiated thyroid cancer. The guideline modifications 2016 include the following matters: indication for fine-needle aspiration biopsy, calcitonin screening, standards for biopsy results, indication for suppressive therapy and thyroid replacement therapy, targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer.

Russian clinical practice guidelines are dedicated to the management of patients with pheochromocytoma and paraganglioma.

Previously we elaborated software for analysis of diabetic foot outpatient clinic (DFOC) performance parameters. In this study we tested this software in 4 DFOCs in several cities. As a result, we obtained main parameters of treatment efficacy which can be base for elaboration of benchmarks for quality management in this field. This software can be helpful for administrators of the healthcare system in planning of measures for treatment results improvement and in assessment of these efforts efficacy.

Syndrome Sipple is the second name of the syndrome of multiple endocrine neoplasia type II (MEN­2A). In 1961 J.H. Sipple described several relatives with medullary thyroid cancer, feohromotsytoma and hyperparathyroidism. The following observation is presented.

Given the unique observation of atypical MEN­1 (mixed version) of a man 48 years old, due to the presence 9 of multiple tumors and hyperplasia in 8 different organs (parathyroid glands, pancreatic and thyroid glands, duodenum, lung, stomach, skin and adrenal glands). The peculiarity of this case is medullary carcinoma of the thyroid gland that is usually associated with the syndrome of MEN­2. The patient had typical clinical hypoglycemic syndrome, however, among all the investigated neuroendocrine tumors of the insulin­producing cells were not available, that doesn’t mean there are not revealed (possibly very small) tumors of the pancreas. At the same time, it is known that clinical manifestations of MEN­1 may be due to the cumulative effect of all complex of the hormones produced simultaneously by several multiple tumors.